HC Wainwright & Co. Maintains Buy on Viridian Therapeutics, Raises Price Target to $40
HC Wainwright & Co. analyst Douglas Tsao maintains Viridian Therapeutics (NASDAQ:VRDN) with a Buy and raises the price target from $35 to $40.
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell
• Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
The Latest Analyst Ratings for Viridian Therapeutics
Over the past 3 months, 6 analysts have published their opinion on Viridian Therapeutics (NASDAQ:VRDN) stock. These analysts…
HC Wainwright & Co. Reiterates Buy on Viridian Therapeutics, Maintains $35 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Viridian Therapeutics (NASDAQ:VRDN) with a Buy and maintains $35 price target.
SVB Leerink Maintains Outperform on Viridian Therapeutics, Raises Price Target to $45
SVB Leerink analyst Thomas Smith maintains Viridian Therapeutics (NASDAQ:VRDN) with a Outperform and raises the price target from $40 to $45.
Credit Suisse Initiates Coverage On Viridian Therapeutics with Outperform Rating, Announces Price Target of $51
Credit Suisse analyst Tiago Fauth initiates coverage on Viridian Therapeutics (NASDAQ:VRDN) with a Outperform rating and announces Price Target of $51.
Benzinga’s Top Ratings Upgrades, Downgrades For December 1, 2022
Upgrades Northcoast Research upgraded the previous rating for SpartanNash Co (NASDAQ:SPTN) from Neutral to Buy. SpartanNash earned $0.55…
Why Leslie’s Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.